Congratulations to GTOP Awardees 2025!
The Geneva Translational Oncology (GTO) is proud to announce the list of 2025 awards.
The projects will be co-led by pairs of clinicians and research scientists, involve the Clinical Pathology Service, focus on human research, and utilize biological material collected at HUG.
- Prof. Dr. Med. F. Simonetta & Prof. S. Hugues, Dre Med. S. Chartier: Decoding the Role of Lymphatic Endothelial Cells in CAR T Cell Therapy Using Spatial Transcriptomics
- Prof. Dr. Med. D. Migliorini & Dr. V. Hamel, Prof. Dr. Med D. Merkler, Prof. Dr. Med K. Schaller, Dr. M. Cuendet: Bridging Immunotherapy and Nanoscale Imaging: a Multimodal Strategy to Combat Glioblastoma
- Dr. Med. T. Koessler & Dr. L. Simo Riudalbas, Dr. C. Corro, Dre. Med. A. Bornand: Integrative Analysis of the POU5F1B Pro-metastatic Factor and the Immune Landscape in Rectal Cancer Response to Chemoradiotherapy
- Prof. P. Meraldi & Prof. P. Nowak-Sliwinska, Dre. Med A. Bornand: Immunogenic Remodeling of the Tumor Microenvironment by a Novel Paclitaxel-Based Drug Combination: Role of cGAS/STING/Type 1 Interferon Signaling
The GTO Award objective is to fund substantial, multidisciplinary translational oncology initiatives that capitalize on the resources of the HUG digital infrastructure. This endeavor is dedicated to deepening our comprehension, management, and treatment of cancer. Central to our mission is the acceleration of the journey from basic scientific discovery to tangible patient benefits.
3 Dec 2025